The first proposed hypothesis for the role of serum irisin levels in CAD is that lower irisin levels cause endothelial dysfunction and reduced coronary blood flow due to reduced nitric oxide (NO) bioavailability. Here, FNDC5 is linked to coronary artery disorder.